United Kingdom prospective diabetes study (UKPDS): 10 Years later;L'Étude clinique du mois «United Kingdom prospective diabetes study»: 10 Ans plus tard

Revue Medicale de Liege

Volumn 63, Issue 10, 2008, Pages 624-629

  Scheen, A J ^a,b   Paquot, N ^b   Lefebvre, P J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Arterial hypertension; Coronary heart disease; HbA1c; Microangiopathy; Mortality; Type 2 diabetes; UKPDS

Indexed keywords

ATENOLOL; CAPTOPRIL; GLUCOSE; METFORMIN;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART INFARCTION; HUMAN; HYPERTENSION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT MONITORING; PERIPHERAL VASCULAR DISEASE; RISK REDUCTION;

BLOOD GLUCOSE; BLOOD PRESSURE MONITORING, AMBULATORY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 54849440849     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Numéro special.- Le diabète sucré dans tous ses états. Rev Med Liège, 2005, 60, 269-631.
2. Diabetes Control and Complications Trial Research Group. - The effect of intensive treatment of diabetes on the development and the progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
3. The Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications Research Group.- Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl JMed, 2000, 342, 381-389.
4. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. - Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005, 353, 2643-2653.
5. UK Prospective Diabetes Study (UKPDS) Group. - Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 837-853.
6. UK Prospective Diabetes Study (UKPDS) Group. - Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 1998, 352, 854-865.
7. Nathan DM, Buse JB, Davidson MB, et al. - Management of hyperglycaemia in type 2 diabetes : a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia, 2006, 49, 1711-1721.
8. Radermecker RP, Philips JC, Jandrain B, et al. - Contrôle glycémique et morbi-mortalité cardio-vasculaire chez le patient diabétique de type 2. Résultats des études ACCORD, ADVANCE et VA-Diabetes. Rev Med Liège, 2008, 63, 511-518.
9. UK Prospective Diabetes Study Group. - Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. Br Med J, 1998, 317, 703-713.
10. UK Prospective Diabetes Study Group. - Efficacy of atenolol and captopril in reducing risk of macrovascular and microavascular complications in type 2 diabetes. UKPDS 38. Br Med J, 1998, 317, 713-720.
11. Scheen AJ. - Les leçons de la «United Kingdom Prospective Diabetes Study». Rev Med Liège, 1998, 53, 576-578.
12. Holman RR, Paul SK, Bethel MA, et al. - 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008, 359, 10.1056/NEJMoa0806470.
13. Holman RR, Paul SK, Bethel MA, et al. - Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med, 2008, 359, 10.1056/NEJ-Moa0806359.
14. Scheen AJ. - Epilogue ... de la «mémoire thérapeutique». Rev Med Liège, 2007, 62, 471-473.
15. Scheen AJ. - Existe-t-il une «mémoire thé rapeutique» en prévention cardio-vasculaire? Rev Med Suisse, 2007, 3, 1864-1869.
16. HOPE/HOPE-TOO Study Investigators. - Long-term effects of ramipril on cardiovascular events and on diabetes. Results of the HOPE study extension. Circulation, 2005, 112, 1339-1346.
17. Swedberg K, Kjekshus J, Snapinn S. - Long-term survival in severe heart failure in patients treated with enalapril : ten year follow-up of CONSENSUS I. Eur Heart J, 1999, 20, 136-139.
18. Scheen AJ. - L'après DCCT, l'étude EDIC. Rev Med Liège, 2000, 55, 187-189.
19. Stettier C, Alleman S, Jüni P, et al. - Glycemic control and macrovascular diseases in types 1 and 2 diabetes mellitus : meta-analysis of randomized trials. Am Heart J, 2006, 152, 27-38.
20. The ADVANCE Collaborative Group. - Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008, 358, 2560-2572.
21. Goh SY, Cooper ME. - The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab, 2008, 93, 1143-1152.
22. American Diabetes Association.- Standards of medical care in diabetes. 2008. Diabetes Care, 2008, 31 (Suppl 1), S12-S54.
23. ADVANCE Collaborative Group. - Effects of a fixed combination of Perindopril and Indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet, 2007, 370, 829-840.
24. Scheen AJ, Krzesinski JM. - ADVANCE : amélioration de la survie et réduction des complications vasculaires et rénales avec la combinaison fixe perindopril-indapamide chez le patient diabétique de type 2. Rev Med Liège, 2007, 62, 639-643.
25. Scheen AJ, Estrella F. - L'étude Steno-2: plaidoyer pour une prise en charge globale et intensive du patient diabétique de type 2. Rev Med Liège, 2003, 58, 109-111.
26. Gæde P, Lund-Andersen H, Parving HH, Pedersen O. - Effect of a multifactorial intervention on mortality in type 2 diabetes. New Engl J Med, 2008, 358, 580-591.